Connection
David Schwartz to Lipopolysaccharide Receptors
This is a "connection" page, showing publications David Schwartz has written about Lipopolysaccharide Receptors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.636 |
|
|
|
-
Brass DM, Hollingsworth JW, McElvania-Tekippe E, Garantziotis S, Hossain I, Schwartz DA. CD14 is an essential mediator of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol. 2007 Jul; 293(1):L77-83.
Score: 0.288
-
Palmer SM, Klimecki W, Yu L, Reinsmoen NL, Snyder LD, Ganous TM, Burch L, Schwartz DA. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant. 2007 Mar; 7(3):693-9.
Score: 0.284
-
Schwartz DA. The genetics of innate immunity. Chest. 2002 Mar; 121(3 Suppl):62S-68S.
Score: 0.051
-
Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, Heine H, Latz E, Monks BG, Schwartz DA, Miyake K, Golenbock DT. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med. 2001 Jul 02; 194(1):79-88.
Score: 0.012